Sec Form 3 Filing - Gates Richard P. @ Walgreens Boots Alliance, Inc. - 2023-04-20

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Gates Richard P. 2. Issuer Name and Ticker or Trading Symbol Walgreens Boots Alliance, Inc. [ WBA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) SVP, Chief Pharmacy Officer (Last) (First) (Middle) C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD 3. Date of Earliest Transaction (MM/DD/YY) 04/20/2023 (Street) DEERFIELD, IL60015 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 26,202.3 ( 1 ) ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to Buy) $ 60.52 11/01/2016 11/01/2023 Common Stock 3,227 D Employee Stock Option (Right to Buy) $ 64.22 11/01/2017 11/01/2024 Common Stock 2,552 D Employee Stock Option (Right to Buy) $ 84.68 11/01/2018 11/01/2025 Common Stock 2,742 D Employee Stock Option (Right to Buy) $ 82.46 11/01/2019 11/01/2026 Common Stock 3,814 D Employee Stock Option (Right to Buy) $ 67.01 ( 3 ) 11/01/2027 Common Stock 7,065 D Employee Stock Option (Right to Buy) $ 79.9 ( 4 ) 11/01/2028 Common Stock 9,073 D Employee Stock Option (Right to Buy) $ 57.38 ( 5 ) 11/01/2029 Common Stock 9,191 D Employee Stock Option (Right to Buy) $ 34.04 ( 6 ) 11/01/2030 Common Stock 10,829 D Employee Stock Option (Right to Buy) $ 47.32 ( 7 ) 11/01/2031 Common Stock 10,951 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Gates Richard P. C/O WALGREENS BOOTS ALLIANCE, INC. 108 WILMOT ROAD DEERFIELD, IL60015 SVP, Chief Pharmacy Officer Signatures /s/ Richard Gates by Cherita Thomas, Attorney-in-Fact 05/01/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes shares underlying restricted stock units ("RSUs") granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "2013 Plan"), RSUs granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "2021 Plan") and shares underlying RSUs issued in lieu of dividends (through April 30, 2023) on the outstanding RSUs. (continued in footnote 2) ( 2 )(continued from footnote 1) RSUs were granted and vest as follows (a) 722 RSUs granted on November 1, 2020 and vest on November 1, 2023; (b) 1,217.5 RSUs granted on November 1, 2021 that vest with respect to 607.5 units on November 1, 2023 and with respect to 610 units on November 1, 2024; and (c) 9,058 RSUs granted on November 1, 2022 that vest with respect to 3,016 units on November 1, 2023, with respect to 3,016 units on November 1, 2024, and with respect 3,026 units on November 1, 2025. ( 3 )The option vests with respect to 2,352 shares on November 1, 2018, with respect to 2,353 shares on November 1, 2019, and with respect to 2,360 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan. ( 4 )The option vests with respect to 3,021 shares on November 1, 2019, with respect to 3,021 shares on November 1, 2020, and with respect to 3,031 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan. ( 5 )The option vests with respect to 3,060 shares on November 1, 2020, with respect to 3,061 shares on November 1, 2021, and with respect to 3,070 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan. ( 6 )The option vests with respect to 3,606 shares on November 1, 2021, with respect to 3,606 shares on November 1, 2022, and with respect to 3,617 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan. ( 7 )The option vests with respect to 3,646 shares on November 1, 2022, with respect to 3,647 shares on November 1, 2023, and with respect to 3,658 shares on November 1, 2024, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2021 Plan.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.